Synageva BioPharma Corp (NASDAQ:GEVA)

98.89
Delayed Data
As of May 01
 +6.93 / +7.54%
Today’s Change
60.19
Today|||52-Week Range
122.88
+6.57%
Year-to-Date

Today’s Trading

Previous close91.96
Today’s open92.34
Day’s range92.34 - 98.98
Volume504,746
Average volume (3 months)322,041
Market cap$3.7B
Dividend yield--
Data as of 4:00pm ET, 05/01/2015

Growth & Valuation

Earnings growth (last year)-73.24%
Earnings growth (this year)-26.24%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)-51.46%
P/E ratioNM
Price/Sales467.65
Price/Book6.97

Competitors

 Today’s
change
Today’s
% change
CTLTCatalent Inc+0.44+1.53%
JUNOJuno Therapeutics In...+2.08+4.87%
XONIntrexon Corp+1.10+2.83%
BLUEbluebird bio Inc+5.75+4.32%
Data as of 4:05pm ET, 05/01/2015

Financials

Last reporting dateApril 29, 2015
EPS forecast (this quarter)-$1.65
Annual revenue (last year)$6.5M
Annual profit (last year)-$192.6M
Net profit margin-2,967.47%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Sanj K. Patel
Chief Operating Officer
Robert B. Bazemore
Corporate headquarters
Lexington, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers